Relentless Venture Fund
Alison Twiner is an experienced advisor and board member with a strong background in marketing and governance. Currently serving as an Advisor at Relentless Venture Fund since 2019, Alison focuses on early-stage investments in health technology. As a Board Member at Keela, Alison contributes to developing solutions for the nonprofit sector. Notably, Alison has held multiple leadership roles at Heart & Stroke, including Past Chair and Vice Chair, influencing significant funding for heart disease and stroke research in Canada. Previous experience includes leadership positions at Facebook, where Alison was a Group Director of Global Marketing Solutions, and roles in eCommerce marketing at companies like Intrawest and Google Inc. Alison holds a Bachelor of Arts in Communications from McGill University and has been instrumental in driving online marketing strategies in various sectors.
This person is not in any teams
Relentless Venture Fund
Relentless has an unwavering commitment to invest in the commercialization of disruptive technology, products, and services that optimize access to care and facilitate a robust continuum of care. We invest in leading-edge clinical research and technologies that manage health risk factors and treat chronic conditions. As technology and mission based investors, we are committed to the development of technologies, products and services that both enhance and promote an individual’s ability to stay optimally healthy and active over an entire lifetime. We target investment at the early stage of a business, the ‘start up’ phase. As early stage investors, we influence product and market development, while tapping into the experience of our seasoned advisors and unique North American network to create additional value. Opportunistically, we include development stage businesses for portfolio balance. Investment Sectors: Preventive health, chronic disease management, seniors' health, digital health, corporate wellness, personal nutrition, behaviour modification, mental wellbeing, neurotech, diabetes, cardiovascular disease, mobility, sensor technology, 3D-printing and healthy longevity.